MENU
PLX
AS OF
Nov 20 closing price
Price
$1.74
Change
-$0.03 (-1.69%)
Capitalization
139.93M
111 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
PLX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Protalix BioTherapeutics (PLX) Earnings Date & Reports

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx... Show more

A.I. Advisor
published Earnings

PLX is expected to report earnings to rise 33.33% to 3 cents per share on March 12

Protalix BioTherapeutics PLX Stock Earnings Reports
Q4'25
Est.
$0.04
Q3'25
Missed
by $0.04
Q2'25
Missed
by $0.15
Q1'25
Missed
by $0.08
Q4'24
Est.
$0.10
The last earnings report on November 13 showed earnings per share of 2 cents, missing the estimate of 7 cents. With 605.35K shares outstanding, the current market capitalization sits at 139.93M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PLX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PLX showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for PLX
A.I. Advisor
published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com